0001558370-24-008313.txt : 20240515 0001558370-24-008313.hdr.sgml : 20240515 20240515170530 ACCESSION NUMBER: 0001558370-24-008313 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20240514 ITEM INFORMATION: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240515 DATE AS OF CHANGE: 20240515 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CAPRICOR THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001133869 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-34058 FILM NUMBER: 24952405 BUSINESS ADDRESS: STREET 1: 8840 WILSHIRE BLVD STREET 2: 2ND FLOOR CITY: BEVERLY HILLS STATE: CA ZIP: 90211 BUSINESS PHONE: (310) 358-3200 MAIL ADDRESS: STREET 1: 8840 WILSHIRE BLVD STREET 2: 2ND FLOOR CITY: BEVERLY HILLS STATE: CA ZIP: 90211 FORMER COMPANY: FORMER CONFORMED NAME: Nile Therapeutics, Inc. DATE OF NAME CHANGE: 20070920 FORMER COMPANY: FORMER CONFORMED NAME: SMI PRODUCTS INC DATE OF NAME CHANGE: 20010206 8-K 1 capr-20240514x8k.htm 8-K
0001133869false--12-3100011338692024-05-142024-05-14

​

​

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

​

FORM 8-K

​

CURRENT REPORT

Pursuant to Section 13 or 15(d) of

The Securities Exchange Act of 1934

​

Date of Report (Date of earliest event reported)

​

May 14, 2024

​

CAPRICOR THERAPEUTICS, INC.

(Exact name of Registrant as Specified in its Charter)

​

    

​

​

Delaware

    

001-34058

    

88-0363465

(State or other jurisdiction
of incorporation)

​

(Commission
File Number)

​

(I.R.S. Employer
Identification No.)

​

    

10865 Road to the Cure, Suite 150, San Diego, California
(Address of principal executive offices)

    

92121
(Zip Code)

​

(858) 727-1755

(Registrant’s telephone number, including area code)

​

Not Applicable

(Former name or former address, if changed since last report)

​

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

​

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

​

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

​

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

​

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

​

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

​

Emerging growth company ☐

​

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻

​

Securities registered pursuant to Section 12(b) of the Act:

​

   

Title of Each Class

    

Trading Symbol(s)

    

Name of Each Exchange on Which
Registered

Common Stock, par value $0.001 per share

CAPR

The Nasdaq Capital Market

​

​

​

​

​

Item 5.03

Amendments to Articles of Incorporation or Bylaws: Change in Fiscal Year.

Amendment to Articles of Incorporation

As previously reported on Form 8-K, on May 14, 2024, at an annual meeting of stockholders of Capricor Therapeutics, Inc. (the “Company”), the stockholders approved an amendment to the Company’s Certificate of Incorporation to increase the number of authorized shares of the Company’s common stock from 50,000,000 to 100,000,000. On May 15, 2024, the Company filed a Certificate of Amendment of Certificate of Incorporation (the “Certificate of Amendment”) with the Secretary of State of Delaware to effect the Amendment, effective as of May 15, 2024.

This description of the Amendment is a summary and is qualified by the complete text of the Certificate of Amendment, a copy of which is attached as Exhibit 3.1 hereto and incorporated herein by reference.

Item 9.01Financial Statements and Exhibits.  

​

(d) Exhibits

​

3.1

Certificate of Amendment of Certificate of Incorporation of Capricor Therapeutics, Inc.

​

​

​

104

​

Cover Page Interactive Data File (formatted as inline XBRL).

​

​

2

​

SIGNATURES

​

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

​

CAPRICOR THERAPEUTICS, INC.

Date:  May 15, 2024

By:

/s/ Linda Marbán, Ph.D.

Linda Marbán, Ph.D.

Chief Executive Officer

​

​

3

 EX-3.1 2 capr-20240514xex3d1.htm EX-3.1

Exhibit 3.1

​

CERTIFICATE OF AMENDMENT

OF

CERTIFICATE OF INCORPORATION

OF

CAPRICOR THERAPEUTICS, INC.

​

Capricor Therapeutics, Inc. (the “Corporation”), a corporation organized and existing under the General Corporation Law of the State of Delaware (the “DGCL”), does hereby certify that:

​

FIRST: The name of the Corporation is Capricor Therapeutics, Inc.

​

SECOND: The original Certificate of Incorporation of the Corporation (formerly known as SMI Products, Inc. and Nile Therapeutics, Inc., respectively) was filed with the Secretary of State of the State of Delaware on January 26, 2007, which was amended by a Certificate of Amendment of Certificate of Incorporation thereafter filed with the Secretary of State of the State of Delaware on November 20, 2013 and a Certificate of Amendment of Certificate of Incorporation thereafter filed with the Secretary of State of the State of Delaware on June 4, 2019 (the “Certificate of Incorporation”).

​

THIRD: The Board of Directors of the Corporation duly adopted resolutions setting forth proposed amendments (the “Certificate of Amendment”) to the Certificate of Incorporation amending the Certificate of Incorporation as follows:

​

The Certificate of Incorporation shall be amended by deleting and substituting the text of the two paragraphs of Article Fourth thereof with the following one paragraph.

​

“(a) Authorized Capital. The total number of shares of all classes of stock which the Corporation shall have authority to issue shall be One Hundred Five Million (105,000,000) shares, consisting of (i) One Hundred Million (100,000,000) shares of common stock, par value $0.001 per share (“Common Stock”), and (ii) Five Million (5,000,000) shares of preferred stock, par value $0.001 per share (“Preferred Stock”).”

​

FOURTH: The Board of Directors of the Corporation declared the Certificate of Amendment to be advisable and directed that the Certificate of Amendment be submitted to the stockholders of the Corporation for consideration thereof.

​

FIFTH: That, pursuant to resolution of its Board of Directors of the Corporation, a meeting of stockholders of the Corporation was duly called and held upon notice in accordance with Section 222 of the Delaware General Corporation Law at which meeting the necessary number of shares as required by statute were voted in favor of the Certificate of Amendment.

​

SIXTH: That the foregoing Certificate of Amendment was duly adopted in accordance with the provisions of Section 242 of the Delaware General Corporation Law.

​

IN WITNESS WHEREOF, the Corporation has caused this Certificate of Amendment to be signed by its President and Chief Executive Officer this 15th day of May, 2024.

​

​

​

​

​

​

​

​

​

​

CAPRICOR THERAPEUTICS, INC.

​

​

​

By:

​

_/s/ Linda Marbán, Ph.D. _________

​

​

Linda Marbán, Ph.D.

​

​

Chief Executive Officer

​

 EX-101.SCH 3 capr-20240514.xsd EX-101.SCH 00090 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 4 capr-20240514_lab.xml EX-101.LAB EX-101.PRE 5 capr-20240514_pre.xml EX-101.PRE XML 7 R1.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Document and Entity Information
May 14, 2024
Document and Entity Information [Abstract]  
Document Type 8-K
Document Period End Date May 14, 2024
Entity File Number 001-34058
Entity Registrant Name CAPRICOR THERAPEUTICS, INC.
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 88-0363465
Entity Address, Address Line One 10865 Road to the Cure, Suite 150
Entity Address, City or Town San Diego
Entity Address, State or Province CA
Entity Address, Postal Zip Code 92121
City Area Code 858
Local Phone Number 727-1755
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.001 per share
Trading Symbol CAPR
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Entity Central Index Key 0001133869
Amendment Flag false
Current Fiscal Year End Date --12-31
EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.1.u2 html 1 23 1 false 0 0 false 0 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://capricor.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports capr-20240514.xsd capr-20240514_lab.xml capr-20240514_pre.xml capr-20240514x8k.htm http://xbrl.sec.gov/dei/2023 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "capr-20240514x8k.htm": { "nsprefix": "capr", "nsuri": "http://capricor.com/20240514", "dts": { "schema": { "local": [ "capr-20240514.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "capr-20240514_lab.xml" ] }, "presentationLink": { "local": [ "capr-20240514_pre.xml" ] }, "inline": { "local": [ "capr-20240514x8k.htm" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 3, "http://xbrl.sec.gov/dei/2023": 3 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 24, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "report": { "R1": { "role": "http://capricor.com/role/DocumentDocumentAndEntityInformation", "longName": "00090 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "Duration_5_14_2024_To_5_14_2024_gOnsffK8oEKseZqs0pWwxA", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "capr-20240514x8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_5_14_2024_To_5_14_2024_gOnsffK8oEKseZqs0pWwxA", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "capr-20240514x8k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://capricor.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://capricor.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Document and Entity Information [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://capricor.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://capricor.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://capricor.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://capricor.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://capricor.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://capricor.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://capricor.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://capricor.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://capricor.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://capricor.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://capricor.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://capricor.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://capricor.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://capricor.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://capricor.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://capricor.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://capricor.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://capricor.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://capricor.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://capricor.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://capricor.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 15 0001558370-24-008313-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001558370-24-008313-xbrl.zip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end XML 17 capr-20240514x8k_htm.xml IDEA: XBRL DOCUMENT 0001133869 2024-05-14 2024-05-14 0001133869 false --12-31 8-K 2024-05-14 CAPRICOR THERAPEUTICS, INC. DE 001-34058 88-0363465 10865 Road to the Cure, Suite 150 San Diego CA 92121 858 727-1755 false false false false false Common Stock, par value $0.001 per share CAPR NASDAQ